This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Rockefeller University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Overview of Inventor Albert Ruzo and His Contributions to Huntington's Disease Research
Introduction: Albert Ruzo is an innovative inventor based in New York, NY, known for his significant contributions to the field of biomedical research, particularly in relation to Huntington's Disease. He holds a patent concerning embryonic cell-based therapeutic candidate screening systems, which aims to advance our understanding and treatment of this debilitating condition.
Latest Patents: Albert Ruzo's noteworthy patent, titled "Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof," revolves around the composition and methods involving isogenic human embryonic stem cells. These cells possess a disease form of the Huntingtin gene (HTT) at the endogenous locus within their genome. Specifically, the disease form includes a polyQ repeat of at least 40 glutamines at the N-terminus of the Huntingtin protein. The genetically-modified cell lines developed by Ruzo recapitulate the characteristics of Huntington's Disease, allowing for a deeper investigation into potential treatments. The inclusion of isogenic controls, which share a similar genetic background, enhances the reliability of these models in drug discovery.
Career Highlights: Ruzo is affiliated with The Rockefeller University, a leading institution known for its focus on scientific research and innovation. His work there underscores a commitment to advancing knowledge in the realms of genetics, cellular biology, and therapeutic development. The patent secured by Ruzo reflects his dedication to leveraging cutting-edge science to combat neurodegenerative diseases.
Collaborations: Throughout his career, Ruzo has collaborated with distinguished colleagues such as Ali Brivanlou and Alessia Deglincerti. Together, they create a synergistic environment that fosters innovative research and the exploration of novel therapeutic avenues for Huntington's Disease.
Conclusion: Albert Ruzo stands out as a pivotal figure in the study of Huntington's Disease, with his patented innovations significantly enabling drug discovery processes. His efforts at The Rockefeller University, along with his collaborative work, contribute to a greater understanding of this tragic condition and offer hope for future breakthroughs in treatment.